ESMO Clinical Practice Guideline interim update on first-line therapy in advanced urothelial carcinoma.
- DOI
- 10.1016/j.annonc.2024.03.001
- Published
- 2024-03-13
- Container
- Ann Oncol
- Publisher
- Not recorded
- Open access
- no
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.annonc.2024.03.001,
title = {ESMO Clinical Practice Guideline interim update on first-line therapy in advanced urothelial carcinoma.},
author = {Powles T and Bellmunt J and Comperat E and De Santis M and Huddart R and Loriot Y and Necchi A and Valderrama BP and Ravaud A and Shariat SF and Szabados B and van der Heijden MS and Gillessen S and ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org.},
year = {2024},
journal = {Ann Oncol},
doi = {10.1016/j.annonc.2024.03.001},
url = {https://doi.org/10.1016/j.annonc.2024.03.001}
}RIS
TY - JOUR TI - ESMO Clinical Practice Guideline interim update on first-line therapy in advanced urothelial carcinoma. AU - Powles T AU - Bellmunt J AU - Comperat E AU - De Santis M AU - Huddart R AU - Loriot Y AU - Necchi A AU - Valderrama BP AU - Ravaud A AU - Shariat SF AU - Szabados B AU - van der Heijden MS AU - Gillessen S AU - ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org. PY - 2024 JO - Ann Oncol DO - 10.1016/j.annonc.2024.03.001 UR - https://doi.org/10.1016/j.annonc.2024.03.001 ER -
APA
T, P., J, B., E, C., M, D. S., R, H., Y, L., A, N., BP, V., A, R., SF, S., B, S., MS, V. D. H., S, G., & clinicalguidelines@esmo.org., E. G. C. E. A. (2024). ESMO Clinical Practice Guideline interim update on first-line therapy in advanced urothelial carcinoma.. Ann Oncol. https://doi.org/10.1016/j.annonc.2024.03.001
Source records
- europe-pmc · retrieved 2026-11-10T20:07:59.602Z